相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autologous tumor lysate-loaded dendritic cell vaccination (DCVax-L) in glioblastoma: Breakthrough or fata morgana?
Matthias Preusser et al.
NEURO-ONCOLOGY (2023)
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma A Phase 3 Prospective Externally Controlled Cohort Trial
Linda M. Liau et al.
JAMA ONCOLOGY (2023)
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models
Filippo Birocchi et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis
Salvatore Cozzi et al.
CURRENT ONCOLOGY (2022)
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
Jana Portnow et al.
CANCER GENE THERAPY (2021)
Neural stem cells secreting bispecific T cell engager to induce selective antiglioma activity
Katarzyna C. Pituch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
Jawad Fares et al.
LANCET ONCOLOGY (2021)
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
Luke Maggs et al.
FRONTIERS IN NEUROSCIENCE (2021)
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
Hila Shaim et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
Jiemiao Hu et al.
SCIENCE ADVANCES (2021)
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
Lisa Belin et al.
BRITISH JOURNAL OF CANCER (2020)
Targeting Natural Killer Cells for Tumor Immunotherapy
Cai Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Stem cell homing: From physiology to therapeutics
Jane L. Liesveld et al.
STEM CELLS (2020)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2019)
Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
Yoshitaka Tanaka et al.
PLOS ONE (2019)
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
Xin Tang et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
Dean Nehama et al.
EBIOMEDICINE (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Roles of EphA1/A2 and ephrin-A1 in cancer
Katsuaki Ieguchi et al.
CANCER SCIENCE (2019)
Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC
Timothy F. Cloughesy et al.
NEURO-ONCOLOGY (2018)
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-\-expressing artificial antigen presenting cells for adoptive cell therapy for glioma
Ayguen Sahin et al.
PLOS ONE (2018)
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy
Serena Pellegatta et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
Zhongzhen Yi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity
Dongrui Wang et al.
JCI INSIGHT (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Tumortropic adipose-derived stem cells carrying smart nanotherapeutics for targeted delivery and dual-modality therapy of orthotopic glioblastoma
Wen-Chia Huang et al.
JOURNAL OF CONTROLLED RELEASE (2017)
The role of bevacizumab in the treatment of glioblastoma
Roberto Jose Diaz et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
CSPG4: a prototype oncoantigen for translational immunotherapy studies
Valeria Rolih et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells
Hui K. Gan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor-homing cytotoxic human induced neural stem cells for cancer therapy
Juli R. Bago et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells
Alix K. Berglund et al.
STEM CELL RESEARCH & THERAPY (2017)
Generation of Off-the-Shelf Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
Jieming Zeng et al.
STEM CELL REPORTS (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Glioblastoma targeted therapy: updated approaches from recent biological insights
M. Touat et al.
ANNALS OF ONCOLOGY (2017)
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
Steven Seaman et al.
CANCER CELL (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Hematopoietic stem cells as a tool for the treatment of glioblastoma multiforme
Igor S. Bryukhovetskiy et al.
MOLECULAR MEDICINE REPORTS (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma
Juli R. Bago et al.
NATURE COMMUNICATIONS (2016)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
Cancer-Testis Antigens and Immunotherapy in the Light of Cancer Complexity
F. Grizzi et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2015)
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
Duane A. Mitchell et al.
NATURE (2015)
Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas
Catherine Flores et al.
ONCOIMMUNOLOGY (2015)
T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
Claudia Geldres et al.
CLINICAL CANCER RESEARCH (2014)
Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution
Rachael Mooney et al.
FUTURE ONCOLOGY (2014)
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Zhao Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours
Justyna Kmiecik et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Natural killer cells in the treatment of high-risk acute leukaemia
Franco Locatelli et al.
SEMINARS IN IMMUNOLOGY (2014)
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
Rachel E. Beard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
Surasak Phuphanich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The Definition of Primary and Secondary Glioblastoma
Hiroko Ohgaki et al.
CLINICAL CANCER RESEARCH (2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy
F. Noyan et al.
CANCER GENE THERAPY (2012)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Migration of mouse-induced pluripotent stem cells to glioma-conditioned medium is mediated by tumor-associated specific growth factors
Shinichiro Koizumi et al.
ONCOLOGY LETTERS (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
Jenny J. Hong et al.
CLINICAL CANCER RESEARCH (2010)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
Jian Gang Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway
J Imitola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
K Nakamura et al.
GENE THERAPY (2004)
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg et al.
LEUKEMIA (2004)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
KS Aboody et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
